找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Nanobiotechnology in Neurodegenerative Diseases; Mahendra Rai,Alka Yadav Book 2019 Springer Nature Switzerland AG 2019 Alzheimers.parkinso

[复制链接]
楼主: Coolidge
发表于 2025-3-28 17:05:30 | 显示全部楼层
Application of Mycogenic Nanoparticles Against Neurodegenerative Diseases,process, besides the conditions used during the process, such as temperature, pH and substrate concentration. Metal nanoparticles associated with polysaccharides and proteins; depict bioactivity related to treatment of diseases such as neurodegenerative diseases. These nanoparticles are ecologically
发表于 2025-3-28 19:24:44 | 显示全部楼层
,Nanobiotechnology in Parkinson’s Disease,ogical fluids, and novel MRI agents for contrast enhancement in imaging applications. Nanotechnology could also revolutionize the PD therapeutic pipeline, which is currently focused on the relief of motor symptoms. To date, the efficacy of nanotechnology in PD treatment has been supported by a large
发表于 2025-3-29 01:38:17 | 显示全部楼层
Selenium Nanoparticles as Therapeutic Agents in Neurodegenerative Diseases,context, the selenium nanoparticles play an important role in the application for neurodegenerative diseases. In this chapter, we explain the green synthesis of selenium nanoparticles using eco-friendly methods, their characterization using various analytical techniques and applications in the diagn
发表于 2025-3-29 05:06:48 | 显示全部楼层
发表于 2025-3-29 10:23:09 | 显示全部楼层
发表于 2025-3-29 12:48:57 | 显示全部楼层
Nanocarrier-Mediated Drug Delivery Systems for Neurodegenerative Diseases,larity, and surface chemistry of nanoparticles are the determinants of efficacy in transporting across BBB. Nanocarriers can be designed in such a way that it does not alter the effect of the drugs. However, care has to be taken when choosing nanomaterials (NM) as some are nonbiodegradable. They can
发表于 2025-3-29 16:44:35 | 显示全部楼层
,Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease,Lipid-based nanosized drug delivery systems seem to be very promising in delivering the entrapped drug to the brain by virtue of their lipidic nature and small size. Lipid-based nanocarriers have the added advantage of very low cytotoxicity and avoidance of P-glycoprotein-mediated efflux activity of
发表于 2025-3-29 23:27:21 | 显示全部楼层
发表于 2025-3-30 01:54:17 | 显示全部楼层
发表于 2025-3-30 05:27:40 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-21 21:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表